Overcoming Barriers to Homegrown CAR-TCR Development in Low & Middle Income Countries (LMICs)
- Examine key challenges in developing CAR-TCR therapies from bench to bedside in low- and middle-income countries, from infrastructure to funding gaps
- Share practical solutions to reduce costs, strengthen local manufacturing capacity, and accelerate clinical translation
- Present clinical data showcasing progress and potential for scalable, sustainable innovation in LMIC settings